American Conference Institute's 11th Advanced Forum on Structuring, Negotiating and Managing Pharma/Biotech Collaborative Agreements

WHEN

  • November 12 8:00 AM - November 14, 2008 12:00 PM

WHERE

  • Helmsley Park Lane Hotel
  • 36 Central Park S
  • New York, NY 10019
  • Map

DESCRIPTION

With pipelines drying up, patent expirations at an all time high and R&D costs through the roof, the stakes in negotiating and maintaining lucrative licensing and collaborations could not be higher. But as the critical nature of these deals increases, so do the challenges and complexities.

Competition is increasing, laws are changing, and M&A activity is heating up. Further, IP valuation contingencies are arising in the wake of the Supreme Court's MedImmune decision, and parties are seeking greater protection for their IP rights and looking to draft termination provisions that allow both parties to walk away with their assets intact. In addition, selecting the right partners, deal structure and compensation analysis are crucial to the success of the deal, and an assessment of these factors must be done early in the process. Lastly, as biotech/pharma look more and more to collaborate with the government and institutional researchers for a competitive edge, they face a distinct culture clash that leads to wheel-spinning, preventing agreements from being reached.

Unlike any other licensing event, attendees will not only get the opportunity to network with and learn from a diverse, front-line faculty of experienced in-house counsel, licensing and business development executives from leading pharmaceutical and biotech companies, including Foley Hoag Partner Beth Arnold, but attendees will also receive practical guidance on how to translate new laws and trends into a winning business strategy and overcome challenges and complexities in negotiating and maintaining the best deal available for their company's needs.

For more information on this conference, please access http://www.americanconference.com.